rgb
DESCRIPTION
rgbTRANSCRIPT
2 23 34 45 57 78 89 9
10 1011 1112 12
12
R G B1 157 144 1602 81 170 2303 104 160 2104 25 76 1285 15 86 1636 52 71 1207 29 96 1638 24 84 1449
10
1 20
2
4
6
8
10
12
14
Chart Title
Row 5 Row 6 Row 7 Row 8 Row 9Row 10 Row 11 Row 12 Row 13 Row 14
1 20
2
4
6
8
10
12
14
Chart Title
Row 5 Row 6 Row 7 Row 8 Row 9Row 10 Row 11 Row 12 Row 13 Row 14
0%
20%
40%
60%
80%
100%
0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
80,000
90,000~ 90 USD bn *
Amgen has its major focus on Adjuvants with 55% of contribution.
Roche is the largest contributor among all the companies with the Top 3 oncology drugs like Avastin, Herceptin & Rituxan.
Novartis is at the Second position in both Adjuvants and Oncology group.
Celgene is oncology focused company having all small molecule drugs in its portfolio.Revlimid is Largest among small molecule
KHK is the only Japanese company among top 5 contributors and it deals with Amgen’s Adjuvant drugs for Japanese Market
Merck & Co major contribution in Adjuvant is indicated by a single drug i.e. Emend
Pfizer being a Diversified company holds position in top 10 Oncology Market
Major three contributors of others areGSK, Bayer, Astellas
Major three contributors of others areInsys Therapeutics, Otsuka, Spectrum
Tota
l Onc
olog
y M
arke
t 201
4
Amgen
Novartis
Roche
Novartis
Celgene
JNJ
JNJ
KHK
BMS
Roche
Elli LillyAstraZeneca
PfizerTakeda
Merck & CoOthers
Core
O
ncol
ogy
Adju
vantMerck & CoSanofiEisaiGSKTevaOthers
0%
20%
40%
60%
80%
100%
0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
80,000
90,000~ 90 USD bn *
Amgen has its major focus on Adjuvants with 55% of contribution.
Roche is the largest contributor among all the companies with the Top 3 oncology drugs like Avastin, Herceptin & Rituxan.
Novartis is at the Second position in both Adjuvants and Oncology group.
Celgene is oncology focused company having all small molecule drugs in its portfolio.Revlimid is Largest among small molecule
KHK is the only Japanese company among top 5 contributors and it deals with Amgen’s Adjuvant drugs for Japanese Market
Merck & Co major contribution in Adjuvant is indicated by a single drug i.e. Emend
Pfizer being a Diversified company holds position in top 10 Oncology Market
Major three contributors of others areGSK, Bayer, Astellas
Major three contributors of others areInsys Therapeutics, Otsuka, Spectrum
Tota
l Onc
olog
y M
arke
t 201
4
Amgen
Novartis
Roche
Novartis
Celgene
JNJ
JNJ
KHK
BMS
Roche
Elli LillyAstraZeneca
PfizerTakeda
Merck & CoOthers
Core
O
ncol
ogy
Adju
vantMerck & CoSanofiEisaiGSKTevaOthers